Showing results (191-200 of 269) with videos related to
Sort By:
Pageof 27
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 9, 2021
Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic RatsCaitlin L Maikawa, Peyton C Chen, Eric T Vuong, et al.Diabetes Technology & Therapeutics|August 3, 2018
Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 DiabetesBruce A Buckingham, Mark P Christiansen, Gregory P Forlenza, et al.The Journal of Pediatrics|October 18, 2005
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitusEva Tsalikian, Nelly Mauras, Roy W Beck, et al.Diabetes Technology & Therapeutics|March 30, 2019
Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 DiabetesGregory P Forlenza, Bruce A Buckingham, Mark P Christiansen, et al.Diabetes Care|January 27, 2011
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset, Rosanna Fiallo-Scharer, Jing Cheng, et al.Pediatric Diabetes|July 13, 2016
Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspensionR Paul Wadwa, H Peter Chase, Dan Raghinaru, et al.Diabetes Care|June 1, 2014
Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes campTrang T Ly, Marc D Breton, Patrick Keith-Hynes, et al.Diabetes Technology & Therapeutics|September 22, 2018
Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes ManagementRebecca N Adams, Molly L Tanenbaum, Sarah J Hanes, et al.Diabetes Technology & Therapeutics|January 26, 2024
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod<sup>®</sup> 5 Automated Insulin Delivery SystemDaniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, et al.Diabetes Technology & Therapeutics|November 23, 2020
Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and PreschoolersLaya Ekhlaspour, Melissa J Schoelwer, Gregory P Forlenza, et al.Pageof 27